Kevin Hsueh

Medicine & Life Sciences

1. Amoxicillin 14%
2. Anti-Bacterial Agents 100%
3. Antimicrobial Stewardship 81%
4. Bacterial Infections 26%
5. Candida 85%
6. Candidemia 77%
7. Cefepime 37%
8. Centers for Medicare and Medicaid Services (U.S.) 35%
9. Cohort Studies 59%
10. Communicable Diseases 23%
11. Comorbidity 17%
12. Confidence Intervals 24%
13. Cross Infection 28%
14. Delivery of Health Care 17%
15. Dentists 38%
16. Drug Evaluation 34%
17. Emergencies 21%
18. Endocarditis 29%
19. Formularies 18%
20. Genes 11%
21. Growth 14%
22. Hand 21%
23. Hospital Mortality 13%
24. Inappropriate Prescribing 42%
25. Infections 59%
26. Interleukin-4 25%
27. Interleukins 26%
28. Interrupted Time Series Analysis 38%
29. L-Amino Acid Oxidase 12%
30. Length of Stay 24%
31. Linezolid 15%
32. Longitudinal Studies 23%
33. Meropenem 17%
34. Mortality 37%
35. Neutropenia 37%
36. Outpatients 42%
37. Patient Safety 33%
38. Pharmaceutical Preparations 23%
39. Pharmacokinetics 21%
40. Prescriptions 33%
41. Referral and Consultation 20%
42. Retrospective Studies 18%
43. Sepsis 30%
44. Skin 15%
45. Surgeons 19%
46. Tazobactam Drug Combination Piperacillin 18%
47. tedizolid 49%
48. Therapeutics 25%
49. Tooth 21%
50. Upper Extremity 25%